The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of of BCCCP.
BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/
To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.
The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.
In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.
The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.
Target Audience: These recertification activities are intended for the Board-Certified Critical Care Pharmacist® (BCCCP), and/or the Board-Certified Emergency Medicine Pharmacist® (BCEMP), and/or the Board-Certified Pediatric Pharmacy Specialist® (BCPPS) and those interested in considerations and strategies for anticoagulation reversal, antibiotics for gram-negative bacterial infections, and Acetaminophen toxicity.
BCCCP/BCEMP Clinical Session To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation ReversalActivity Number: 0204-9999-24-327-H01-P Contact Hour(s): 1.50 Activity Type: Application Based Learning Objectives
- Summarize available anticoagulant agents and the literature surrounding their use.
- Evaluate the main pillars of anticoagulation reversal to assess when reversal is clinically appropriate.
- Develop a comprehensive anticoagulation reversal plan with consideration of patient-specific factors.
|
BCPPS/BCCCP Clinical Session New and Pipeline Antibiotics for Gram-Negative Bacterial InfectionsActivity Number: 0204-9999-24-254-H01-P Contact Hour(s): 1.50 Activity Type: Application Based Learning Objectives
- Compare the spectrum of activity, pharmacokinetics, and pharmacodynamic properties of newly approved antibiotics for the treatment of difficult-to-treat gram-negative bacterial infections in adult and pediatric populations.
- Interpret biomedical literature including study design and methodology, significance of reported data and conclusions, limitations, and applicability of study results to adult and pediatric patients with difficult-to-treat gramnegative bacterial infections.
- Given a description of an adult or pediatric patient with a difficult-to-treat gram-negative infection, design an antibiotic regimen that reflects the application of the best available evidence and current guidelines.
|
BCPPS/BCCCP/BCEMP Clinical Session Nick-NAC APAP WhackActivity Number: 0204-9999-24-278-H01-P Contact Hour(s): 1.50 Activity Type: Application Based Learning Objectives
- Evaluate current guideline recommendations for patients presenting with acetaminophen toxicity.
- Develop an effective treatment regimen for the management of a patient presenting with acetaminophen toxicity.
- Develop monitoring strategies for the different medications used to treat acetaminophen toxicity.
- Design an effective treatment plan for patients requiring adjunctive treatment options for acetaminophen toxicity.
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.